4-Fluoropethidine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Dcirovic (talk | contribs) at 04:22, 14 May 2016 (corected authors list (CS1 maint)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

4-Fluoropethidine
Clinical data
Other names4-Fluoromeperidine, 4-Fluoropethidine
ATC code
  • none
Identifiers
  • ethyl 4-(4-fluorophenyl)-1-methylpiperidine-4-carboxylate
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC15H20FNO2
Molar mass265.322 g/mol g·mol−1
3D model (JSmol)
  • FC1=CC=C(C2(CCN(C)CC2)C(OCC)=O)C=C1
  • InChI=1S/C15H20FNO2/c1-3-19-14(18)15(8-10-17(2)11-9-15)12-4-6-13(16)7-5-12/h4-7H,3,8-11H2,1-2H3 checkY
  • Key:CHOQGLPFQOQESN-UHFFFAOYSA-N checkY
  (verify)

4-Fluoropethidine is a drug that is a derivative of pethidine (meperidine), which combines pethidine's opioid analgesic effects with increased monoamine reuptake inhibition. It is around 50% less potent than pethidine as an opioid analgesic, but conversely is 50% more potent as a dopamine reuptake inhibitor, with other derivatives such as the 4-iodo and 3,4-dichloro analogues being even more potent dopamine reuptake inhibitors again. However none of these compounds substitute for cocaine or produce stimulant effects in animals, suggesting that they still act primarily as opioid analgesic drugs in practice.[1] Its action and degree of relation to pethidine means that it may be controlled in those countries which have laws about controlled-substance analogues; it is not itself listed in the Controlled Substances Act 1970.[2]

See also

References

  1. ^ "Synthesis and biological evaluation of meperidine analogues at monoamine transporters". Journal of Medicinal Chemistry. 48 (5): 1336–43. March 2005. doi:10.1021/jm0401614. PMID 15743177. {{cite journal}}: Cite uses deprecated parameter |authors= (help)
  2. ^ http://www.deadiversion.usdoj.gov/fed_regs/quotas/2015/quotas/drugreg/index.html